Micellar solubilization of intestinal lipids after ursodeoxycholic acid therapy in short bowel patients and healthy controls
- PMID: 7254441
Micellar solubilization of intestinal lipids after ursodeoxycholic acid therapy in short bowel patients and healthy controls
Similar articles
-
Fat absorption after infusing bile salts into the human small intestine.Gastroenterology. 1974 Jul;67(1):7-18. Gastroenterology. 1974. PMID: 4366283 No abstract available.
-
Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.Gastroenterology. 1980 Jun;78(6):1412-8. Gastroenterology. 1980. PMID: 7372061 Clinical Trial. No abstract available.
-
Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.Z Gastroenterol. 2004 Jul;42(7):583-9. doi: 10.1055/s-2004-813059. Z Gastroenterol. 2004. PMID: 15248106
-
Intestinal contents in patients with viral hepatitis after a lipid meal.Gastroenterology. 1970 Mar;58(3):379-87. Gastroenterology. 1970. PMID: 5437992 No abstract available.
-
Casebook: diagnosing chronic diarrhoea.Practitioner. 2005 Oct;249(1675):683-4, 686, 688 passim. Practitioner. 2005. PMID: 16237963 Review. No abstract available.
Cited by
-
Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.J Clin Invest. 1992 Feb;89(2):420-31. doi: 10.1172/JCI115601. J Clin Invest. 1992. PMID: 1371123 Free PMC article.
-
Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.Dig Dis Sci. 1992 Aug;37(8):1217-27. doi: 10.1007/BF01296563. Dig Dis Sci. 1992. PMID: 1379904
-
Disorder of bile acid metabolism in children with short bowel syndrome.J Gastroenterol. 1997 Aug;32(4):472-9. doi: 10.1007/BF02934085. J Gastroenterol. 1997. PMID: 9250893
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical